Skip to main content

Innovative Approach to Overcome Antibiotic Resistance

September 2, 2019

Researchers from the UNC School of Medicine have discovered a new method of increasing the susceptibility of staphylococcus aureus bacteria to antibiotics through the addition of new molecules that increase membrane permeability of the bacteria. This significant discovery will be the basis of additional research on increasing the effectiveness of existing antibiotics.

UNC Health Care Launches Telehealth Solution

September 2, 2019

In partnership with American Well, UNC Health Care launched a new application that allows patients to engage in video visits with providers. The application is accessible through a one-click workflow in the My UNC Chart patient portal. Providers can receive notifications, access patient information and conduct the video visit without leaving the Epic environment.

New Master’s Program Aims to Provide Innovative Solutions for Care Delivery

September 2, 2019

The UNC School of Medicine’s Department of Allied Health Sciences has introduced a new online master’s degree program in clinical laboratory science targeting working professionals. Laboratory science has the potential to play a critical role in care transformation, yet the field experiences a statewide-shortage of trained personnel. 

UNC Medical Students placed first at LabCorp Healthcare Case Competition

May 2, 2019

UNC first year medical students placed first at the inaugural LabCorp Healthcare Competition. The competition involved developing a strategic plan to help patients learn about savings they could capitalize on by having their labs done at a LabCorp facility, outside of a hospital or clinic in-house lab.

UNC’s Jon Collins named as Chief Scientific Officer of Pinnacle Hill, LLC

April 23, 2019

Pinnacle Hill, LLC, an innovative partnership between UNC Chapel Hill and Deerfield Management that strives to help UNC scientists discover new medicine, has appointed Jon Collin, PhD as Chief Scientific Officer. At Pinnacle Hill, Dr. Collins will lead the company’s innovative drug discovery and development initiatives.